The goal of this program is to increase the health care professional’s ability to: analyze clinical data with use of HER2-targeted antibody-drug conjugates in HER2-expressing solid tumors and identify potential adverse events.

Join us for an engaging live symposium where two leading upper gastrointestinal (GI) cancer experts will explore the latest advances in the management of gastric, gastroesophageal junction, and esophageal cancers (upper GI cancers).

Explore the predominant AKI phenotypes seen in patients with advanced liver disease. Faculty will provide clarity on distinguishing features and clinical relevance to inform the differential diagnosis process.

This program addresses the importance of comprehensive molecular testing in metastatic colorectal cancer (mCRC) and outlines recent updates in clinical practice guideline recommendations for various molecular tests in mCRC.

After the session, learners can explain the pathological processes of the common forms of dementia, summarize epidemiological trends of dementia in Tennessee/USA, and know the benefits of proactive screening as it relates to health outcomes.

After the session, learners can articulate the typical treatment approach to dementia medications, compare different medication treatment approach, and justify when to discontinue medication.

Join us for this live webinar, where two expert faculty will delve into the latest clinical evidence and professional guidelines for utilizing CGM.

This course covers the clinical issues most relevant to hospitalists and other clinicians who care for inpatients. Taught by UCSF’s top teachers and selected guest faculty, the course highlights recent advances and current controversies.

Join us for a live webinar where leading experts in CAR T-cell therapy and multiple myeloma (MM) will discuss solutions for overcoming persistent gaps in CAR T-cell care coordination.